Henry Ford Seeks Tinnitus Patients for Vagal Nerve Stimulation Clinical Trial
Henry Ford Health System is one of four sites worldwide recruiting patients for a clinical trial that will test the effectiveness and safety of the vagal nerve stimulator – a small, surgically implanted device that uses nervous system stimuli to rewire parts of the brain – for the treatment of tinnitus. Eligible participants are ages 22-65, who have been diagnosed with subjective tinnitus due to hearing loss with sensorineural aspects and at least some tonal quality of the tinnitus. Participants must have experienced tinnitus (unilateral or bilateral) for at least one year. For more information, call (248) 661-7211 or visit www.tinnitustrial.com.
For more information about the clinical trial visit https://bit.ly/1maj6eb
Henry Ford Launches Clinical Trial for Tinnitus Caused by Trauma, Infection
Henry Ford Health System has launched a clinical trial to investigate AM-101, a gel injected into the middle ear, to determine its safety and effectiveness in lessening the excessive signaling to the brain that occurs with acute inner ear tinnitus. Eligible participants are ages 18-75, who have experienced tinnitus for three months or fewer brought on by acoustic trauma, barotrauma, operation on the middle ear, traumatic perforation of the eardrum or middle ear infection. For more information, call (248) 661-7211 or visit www.tinnitus-study.info.
For more information about the trial visit https://bit.ly/1peyyxL
